Cargando…

STING Agonists as Cancer Therapeutics

SIMPLE SUMMARY: Immunotherapies have revolutionized the field of cancer therapeutics, yet a substantial subset of patients fail to respond. Recent efforts have focused on identifying targets that could elicit or augment anti-tumor immune responses. One such novel target is STING or stimulator of int...

Descripción completa

Detalles Bibliográficos
Autores principales:	Amouzegar, Afsaneh, Chelvanambi, Manoj, Filderman, Jessica N., Storkus, Walter J., Luke, Jason J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8198217/ https://www.ncbi.nlm.nih.gov/pubmed/34070756 http://dx.doi.org/10.3390/cancers13112695

Ejemplares similares

STINGing the Tumor Microenvironment to Promote Therapeutic Tertiary Lymphoid Structure Development
por: Filderman, Jessica N., et al.
Publicado: (2021)

STING agonist-based treatment promotes vascular normalization and tertiary lymphoid structure formation in the therapeutic melanoma microenvironment
por: Chelvanambi, Manoj, et al.
Publicado: (2021)

Finding the right help in the tumor microenvironment
por: Filderman, Jessica N., et al.
Publicado: (2022)

Cutaneous Melanoma: Mutational Status and Potential Links to Tertiary Lymphoid Structure Formation
por: Salem, Deepak, et al.
Publicado: (2021)

STING Agonists/Antagonists: Their Potential as Therapeutics and Future Developments
por: Guerini, Danilo
Publicado: (2022)

More fuel for the fire: Gut microbes and toxicity to immune agonist antibodies in cancer
por: Chelvanambi, Manoj, et al.
Publicado: (2021)

Trial watch: STING agonists in cancer therapy
por: Le Naour, Julie, et al.
Publicado: (2020)

Challenges and Opportunities in the Clinical Development of STING Agonists for Cancer Immunotherapy
por: Motedayen Aval, Leila, et al.
Publicado: (2020)

Dendritic cell vaccines targeting tumor blood vessel antigens in combination with dasatinib induce therapeutic immune responses in patients with checkpoint-refractory advanced melanoma
por: Storkus, Walter J, et al.
Publicado: (2021)

Discovery of Novel STING Inhibitors Based on the Structure of the Mouse STING Agonist DMXAA
por: Chang, Jiajia, et al.
Publicado: (2023)

ExoSTING, an extracellular vesicle loaded with STING agonists, promotes tumor immune surveillance
por: Jang, Su Chul, et al.
Publicado: (2021)

STING palmitoylation as a therapeutic target
por: Hansen, Anne Louise, et al.
Publicado: (2019)

cGAS-STING pathway in oncogenesis and cancer therapeutics
por: Hoong, Brandon Yi Da, et al.
Publicado: (2020)

Combination of Irreversible Electroporation and STING Agonist for Effective Cancer Immunotherapy
por: Go, Eun-Jin, et al.
Publicado: (2020)

Anticancer Effect of STING Agonist-Encapsulated Liposomes on Breast Cancer
por: Zhang, Jibing, et al.
Publicado: (2023)

Effects of STING stimulation on macrophages: STING agonists polarize into “classically” or “alternatively” activated macrophages?
por: Ohkuri, Takayuki, et al.
Publicado: (2017)

Tumor-targeted delivery of a STING agonist improves cancer immunotherapy
por: Wu, You-tong, et al.
Publicado: (2022)

STING agonist promotes CAR T cell trafficking and persistence in breast cancer
por: Xu, Nuo, et al.
Publicado: (2020)

Potential Therapeutic Value of the STING Inhibitors
por: Zhang, Shangran, et al.
Publicado: (2023)

Epigenetic state determines the in vivo efficacy of STING agonist therapy
por: Falahat, Rana, et al.
Publicado: (2023)

Toll-Like Receptor 9 Agonists in Cancer
por: Karapetyan, Lilit, et al.
Publicado: (2020)

Unlocking STING as a Therapeutic Antiviral Strategy
por: Paulis, Annalaura, et al.
Publicado: (2023)

Monitoring and Modulating Diet and Gut Microbes to Enhance Response and Reduce Toxicity to Cancer Treatment
por: Knisely, Anne, et al.
Publicado: (2023)

Overcoming challenges in the delivery of STING agonists for cancer immunotherapy: A comprehensive review of strategies and future perspectives
por: Huang, Cuiqing, et al.
Publicado: (2023)

Immunotherapy with STING and TLR9 agonists promotes synergistic therapeutic efficacy with suppressed cancer-associated fibroblasts in colon carcinoma
por: Hajiabadi, Sare, et al.
Publicado: (2023)

The cGAS–STING pathway as a therapeutic target in inflammatory diseases
por: Decout, Alexiane, et al.
Publicado: (2021)

Advances of MnO(2) nanomaterials as novel agonists for the development of cGAS-STING-mediated therapeutics
por: Zhang, Tangxin, et al.
Publicado: (2023)

Hornet Sting
por: Finlayson, Walter J.
Publicado: (1908)

Combination of STING and TLR 7/8 Agonists as Vaccine Adjuvants for Cancer Immunotherapy
por: Bhatnagar, Shubhmita, et al.
Publicado: (2022)

Effector and Regulatory T Cell Trafficking in Corneal Allograft Rejection
por: Amouzegar, Afsaneh, et al.
Publicado: (2017)

Overcoming resistance to STING agonist therapy to incite durable protective antitumor immunity
por: Lemos, Henrique, et al.
Publicado: (2020)

Probiotic Engineering and Targeted Sonoimmuno‐Therapy Augmented by STING Agonist
por: Lu, Dan, et al.
Publicado: (2022)

Structural and Biological Evaluations of a Non-Nucleoside STING Agonist Specific for Human STING(A230) Variants
por: Tang, Zhichao, et al.
Publicado: (2023)

Masso Therapeutics and Scorpion Stings
por: White, H. P. Esmonde
Publicado: (1889)

STING agonist inflames the pancreatic cancer immune microenvironment and reduces tumor burden in mouse models
por: Jing, Weiqing, et al.
Publicado: (2019)

Synergistic Effects of Azithromycin and STING Agonist Promote IFN-I Production by Enhancing the Activation of STING-TBK1 Signaling
por: Petcharat, Kanoktip, et al.
Publicado: (2023)

Endosomolytic Polymersomes Increase the Activity of Cyclic Dinucleotide STING Agonists to Enhance Cancer Immunotherapy
por: Shae, Daniel, et al.
Publicado: (2019)

STING Signaling and Skin Cancers
por: Sato, Sayaka, et al.
Publicado: (2021)

STING activation in cancer immunotherapy
por: Su, Ting, et al.
Publicado: (2019)

Update on vaccine development for renal cell cancer
por: Chi, Nina, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_gcubs4oi7smnhubqc6hhb12r04